Abpro Holdings Inc. (ABPO) vs Finch Therapeutics Group, Inc. (FNCHQ)

Abpro Holdings Inc. and Finch Therapeutics Group, Inc. are both Biotechnology companies. Finch Therapeutics Group, Inc. is the larger, with a market value of $1.6M against $1.4M — 1.1× the size. Finch Therapeutics Group, Inc. has negative trailing earnings, so its P/E is not meaningful; Abpro Holdings Inc. trades at 0.2×. Across the 7 metrics below, Abpro Holdings Inc. leads on 5 and Finch Therapeutics Group, Inc. on 2.

Valuation

Metric ABPO FNCHQ Biotechnology median
P/E 0.20 n/m 7.88
P/S n/m 27.07 11.47
P/B n/m 1.17 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.41 n/m 0.74
EV/Sales n/m 47.86 10.73
Earnings yield 500.00% (85.22%) (28.84%)
Free cash flow yield (311.42%) (100.64%) (23.03%)

Profitability

Metric ABPO FNCHQ Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (20.18%) (67.28%) (57.72%)
Return on assets 46.10% (25.20%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABPO FNCHQ Biotechnology median
Revenue growth (TTM) — (96.00%) 5.64%
EPS growth (last fiscal year) 94.15% 35.36% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ABPO FNCHQ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.62 3.87 4.73
Net debt to EBITDA 0.01 0.31 0.96

Dividend

Metric ABPO FNCHQ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ABPO FNCHQ Biotechnology median
Market cap 1.42m 1.57m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack